As per MRFR analysis, the India Infertility Market Size was estimated at 113.01 (USD Million) in 2024The India Infertility Market Industry is expected to grow from 127.5(USD Million) in 2025 to 872.5 (USD Million) by 2035. The India Infertility Market CAGR (growth rate) is expected to be around 19.106% during the forecast period (2025 - 2035).
Key India Infertility Market Trends Highlighted
The India Infertility Market is experiencing significant growth driven by rising awareness about reproductive health issues and an increase in infertility rates attributed to lifestyle changes, delayed marriages, and urbanization. As more couples seek assistance, the acceptance of assisted reproductive technologies like in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) is increasing. Furthermore, heightened government initiatives focusing on maternal health underscore a push towards improving fertility treatment access. There are abundant opportunities to be explored within this market, particularly in tier II and III cities where awareness about infertility treatments is still developing.
As healthcare infrastructure improves in these regions, fertility clinics and specialized healthcare providers can capture this underserved segment. The rise of telemedicine also offers a unique avenue for delivering fertility consultations and support, making treatments more accessible to couples in remote areas. Recent trends show a growing inclination towards holistic approaches to fertility, which encompass not just medical treatments but also lifestyle and dietary changes. Additionally, a surge in partnerships between healthcare providers and technology firms is fostering innovative solutions such as mobile applications for tracking fertility cycles.
The collaboration between hospitals and research institutions is also witnessing a boost, resulting in improved research and development of new treatments and therapies. As India continues to prioritize healthcare advancements, the infertility market is likely to see a blend of traditional practices and modern technology working together to meet the needs of individuals seeking fertility solutions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Infertility Market Drivers
Rising Infertility Rates Due to Lifestyle Changes
In India, the rise in infertility rates can be attributed to various lifestyle changes, including the increasing trend of late marriages, sedentary lifestyles, and unhealthy dietary habits. According to the Indian Society of Assisted Reproduction, the fertility rate has been declining, with studies indicating that approximately 10-15% of couples experience infertility issues. This statistic is compounded by urbanization and the growing preference for nuclear families.With the modernization of lifestyles, factors such as increased stress levels and environmental exposures have been recognized as critical contributors to infertility. As awareness grows about these issues, the India Infertility Market Industry is likely to see an increased demand for assisted reproductive technology (ART) and fertility treatments, driven by couples seeking solutions to combat these challenges.
Government Initiatives and Policy Support
The Indian government has recognized the importance of addressing infertility as a public health issue. Initiatives such as the National Health Mission and various health policies aim to promote reproductive health services, which have positive implications for the India Infertility Market Industry. Furthermore, supportive policies for the establishment and regulation of fertility clinics and the rising number of ART centers across the nation are easing accessibility for couples.By 2022, the Ministry of Health and Family Welfare reported the establishment of over 400 ART clinics across India, which illustrates a commitment to improving fertility services and ultimately driving market growth.
Technological Advancements in Fertility Treatments
Technological advancements in fertility treatments are a significant driver of the India Infertility Market Industry's growth. Innovations such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) have revolutionized reproduction options. The increasing availability and affordability of these technologies have led to a higher success rate of treatments, attracting more couples to seek help.Reports from the Reproductive Health Unit have noted that the success rate of IVF treatments has reached up to 50-60% for women under 35. This improvement in success rates significantly boosts patient confidence and contributes to market expansion.
Increased Awareness and Acceptance of Fertility Treatments
Over the past decade, there has been a marked increase in awareness and social acceptance surrounding infertility and fertility treatments in India. Educational campaigns initiated by healthcare providers and organized groups have played a vital role in destigmatizing fertility issues, enabling couples to seek assistance without social apprehensions. According to the Rs. 12,000 crore study by the Indian Council of Medical Research on reproductive health, it was found that more than 80% of individuals are open to the idea of seeking ART-related services when fertility issues arise.This newfound openness and the growing demand for treatment options are directly contributing to the India Infertility Market Industry's prospects.
India Infertility Market Segment Insights
Infertility Market Sex Insights
The India Infertility Market, particularly focusing on the aspect of Sex, is gaining considerable attention due to rising issues related to infertility among couples. Factors contributing to the escalating demand for infertility treatments include urbanization, lifestyle changes, and an increased awareness of reproductive health. The market exhibits a notable segmentation in terms of the characteristics of male and female infertility, as well as cases classified as unexplained infertility.
This delineation is critical as it allows for targeted treatment strategies and better patient management.In recent years, the male infertility segment has drawn significant attention, given that a considerable proportion of infertility cases are attributed to male factors. Conditions such as low sperm count and motility are becoming increasingly recognized, pushing the industry to focus more on male reproductive health. On the other hand, the female infertility segment continues to be a dominant player, with a diverse array of causes ranging from polycystic ovary syndrome (PCOS) to advanced age, leading to a greater demand for assisted reproductive technologies.
Additionally, unexplained infertility remains a perplexing challenge that impacts many couples, emphasizing the need for advanced diagnostic technologies and solutions tailored to ensure successful conception. As awareness and education around infertility in India grow, coupled with advancements in medical technology and treatment methodologies, the overall India Infertility Market shows potential for significant developments in addressing these conditions effectively. The interplay of societal perceptions, medical advancements, and individual experiences shapes the landscape of infertility in India, resulting in a continuously evolving market that holds promise for better healthcare solutions tailored around these critical segments.
Furthermore, government initiatives and health programs focusing on reproductive health are expected to facilitate enhanced access to infertility treatments, further contributing to market expansion. Overall, the India Infertility Market continues to reflect dynamic trends and opportunities, with its focus on Sex providing extensive insights into the varying needs and preferences of those affected by infertility.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Infertility Market Diagnosis Insights
The Diagnosis segment of the India Infertility Market encompasses a variety of testing services aimed at identifying the underlying causes of infertility in both men and women. This segment is crucial as it forms the basis for effective treatment strategies. Men Diagnostic Tests focus on evaluating sperm quality, motility, and overall reproductive health, which is essential considering that male factors contribute to nearly half of all infertility cases in India. Women Diagnostic Tests, on the other hand, assess ovulation, hormonal balance, and structural anomalies which are equally important, given that a significant portion of infertility issues arise from female reproductive health.
General Diagnostic Tests provide a comprehensive approach to fertility evaluation, integrating both male and female assessments, thus playing a significant role in guiding couples through their fertility journey. The increasing awareness of reproductive health and advancements in diagnostic technologies are driving growth in this segment, highlighting the necessity for accurate and timely diagnosis as a critical first step in the infertility treatment process within the broader India Infertility Market landscape.
Infertility Market Drugs Insights
The Drugs segment within the India Infertility Market plays a pivotal role in addressing the rising concerns of infertility in the region, influenced by factors such as lifestyle changes and increasing awareness about reproductive health. Within this segment, Clomiphene Citrate and Letrozole are notable for their effectiveness in stimulating ovulation, making them essential for couples facing challenges in conceiving. Hormone Treatment is crucial for individuals with hormonal imbalances, contributing significantly to treatment outcomes. Moreover, Serophene serves as a vital medication for triggering ovulation and restoring the reproductive cycle.
The market for these treatments reflects a growing acceptance and innovation in reproductive health solutions, seen in the increasing demand for fertility drugs across various demographics. The significance of these medications is further enhanced by supportive government policies that aim to improve healthcare accessibility, making these drugs an integral part of the healthcare narrative in India. Overall, the Drugs segment is poised for growth, driven by advancements in medical technologies and the growing pool of patients seeking effective infertility treatments.
Infertility Market Technology Insights
The Technology segment of the India Infertility Market plays a crucial role in improving reproductive health and offering solutions to couples facing challenges in conceiving. This segment encompasses various advanced techniques, including Assisted Reproductive Technology (ART), Intrauterine Insemination (IUI), and surgical interventions aimed at enhancing fertility. Assisted Reproductive Technology stands out as a significant contributor, providing options like in vitro fertilization (IVF) that assist many couples in overcoming infertility issues.IUI is also essential, as it offers a less invasive approach, enabling quicker conception opportunities for many.
Surgical methods, on the other hand, are vital for addressing underlying reproductive health issues, significantly improving the chances of successful pregnancies. The growing prevalence of infertility in India, driven by factors such as changing lifestyles and delayed childbearing, continues to bolster the demand for these innovative technologies. With increased access and affordability, particularly in urban areas, the Technology segment of the India Infertility Market presents expansive growth opportunities, making it an integral part of the healthcare ecosystem.As awareness increases and societal perceptions shift, the usage of these technologies is expected to rise, supporting couples in their journey towards parenthood.
India Infertility Market Key Players and Competitive Insights
The India Infertility Market has experienced significant growth in recent years, driven by increasing awareness about infertility issues, advancements in reproductive technology, and evolving societal norms regarding family planning. With a large population seeking effective solutions for reproductive health challenges, the market is characterized by a mix of established players and emerging clinics offering innovative treatments. Competitive insights reveal that the industry is highly dynamic, with organizations increasingly focusing on customer-centric approaches, personalized treatment plans, and cutting-edge technology to enhance success rates. Furthermore, factors such as partnerships with healthcare providers, investments in research and development, and marketing strategies have become essential for gaining a competitive edge in this burgeoning field.
Max Healthcare stands out in the India Infertility Market due to its comprehensive services and strong market presence. Known for its extensive network of clinics and hospitals, Max Healthcare emphasizes a patient-centric approach, providing tailored infertility treatments that cater to the diverse needs of couples facing reproductive challenges. The organization's strength lies in its experienced medical professionals and support staff, which contribute to high success rates in assisted reproductive technologies such as IVF and IUI. Max Healthcare's commitment to quality care, combined with state-of-the-art facilities and a focus on continuous improvement, allows it to maintain a leading position in the competitive landscape. Additionally, collaborations with leading medical researchers and institutions further bolster its reputation as a trusted provider in the infertility sector.
Bourn Hall Fertility Clinic is another formidable player in the India Infertility Market, recognized for its pioneering approach reproductive medicine. The clinic offers a range of services including IVF, egg freezing, and fertility preservation, which are tailored to meet the specific needs of individuals and couples. Bourn Hall has established a strong presence in the country by focusing on patient education and transparency, thereby enhancing patient trust and satisfaction.
The organization's strengths are derived from its highly trained specialists and cutting-edge laboratory facilities, enabling it to achieve impressive success rates. Additionally, Bourn Hall has pursued strategic partnerships and collaborations within the healthcare ecosystem, allowing it to expand its service offerings and reach. This ongoing commitment to innovation, combined with a patient-first ethos, positions Bourn Hall Fertility Clinic as a key player in the Indian infertility market landscape.
Key Companies in the India Infertility Market Include
India Infertility Market Industry Developments
In recent months, the India Infertility Market has witnessed significant developments. Notably, in May 2023, Max Healthcare announced the opening of a new fertility clinic in Delhi, expanding its reach in assisted reproductive technologies. Bourn Hall Fertility Clinic also introduced advanced IVF services in Vadodara in June 2023, demonstrating its commitment to innovative treatments. Additionally, Nova IVF has been actively engaging in partnerships with local hospitals to enhance patient accessibility, strengthening its market presence.
On the merger and acquisition front, Indira IVF was reported to have acquired a small chain of fertility clinics in Punjab in April 2023, bolstering its capacity and geographic footprint. The market is experiencing robust growth, with the valuation of major companies like Cloudnine and Kiran Hospital seeing a notable increase due to rising awareness and advancements in fertility treatments. Over the past couple of years, companies like Manipal Fertility and Ziva Fertility have also enhanced their service offerings to cater to the growing demand in India, where government initiatives are actively promoting reproductive health. Furthermore, certain states are implementing policies to improve access to infertility treatments for couples across various socio-economic strata.
India Infertility Market Segmentation Insights
Infertility MarketSexOutlook
Infertility MarketDiagnosisOutlook
Infertility MarketDrugsOutlook
Infertility MarketTechnologyOutlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 113.01(USD Million) |
| MARKET SIZE 2024 | 127.5(USD Million) |
| MARKET SIZE 2035 | 872.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 19.106% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Max Healthcare, Bourn Hall Fertility Clinic, AFC Advanced Fertility Centre, Kiran Hospital, Nova IVF, Lilavati Hospital, Cloudnine, Miracles Mediclinic, Indira IVF, K J Somaiya Medical College and Research Centre, Manipal Fertility, MRT Fertility, Fortis La Femme, Sankalp Indo UK Fertility, Ziva Fertility |
| SEGMENTS COVERED | Sex, Diagnosis, Drugs, Technology |
| KEY MARKET OPPORTUNITIES | Increased IVF awareness programs, Expanding telemedicine for consultations, Affordable fertility treatments demand, Enhanced egg/sperm freezing facilities, Rising adoption of holistic therapies |
| KEY MARKET DYNAMICS | rising infertility rates, increasing awareness and education, advancements in reproductive technology, growing acceptance of assisted reproduction, supportive government policies |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The projected market size of the India Infertility Market in 2024 is valued at 127.5 million USD.
By 2035, the estimated market size of the India Infertility Market is expected to reach 872.5 million USD.
The expected CAGR for the India Infertility Market from 2025 to 2035 is 19.106%.
In 2024, the market size for males in the India Infertility Market is valued at 30.0 million USD.
By 2035, the market size for females in the India Infertility Market is projected to reach 350.0 million USD.
The market value for unexplained infertility cases in 2024 is 47.5 million USD.
Key players in the India Infertility Market include Max Healthcare, Bourn Hall Fertility Clinic, and Indira IVF among others.
The India Infertility Market offers growth opportunities driven by increasing awareness and advancements in fertility treatments.
The India Infertility Market may face challenges such as high treatment costs and regulatory hurdles.
Expected applications driving growth in the India Infertility Market include IVF, IUI, and fertility preservation techniques.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
